<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1817-1387'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>IHC - 34 Beta E12(HMWCK) </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">IHC - 34 Beta E12(HMWCK) </h1>
<div class="post-text">
<p><strong>Immunohistochemistry (IHC) - 34 Beta E12 (High Molecular Weight Cytokeratin, HMWCK) test</strong> stands as an essential tool in the realm of medical diagnostics, specifically in the field of pathology. This diagnostic method utilizes an antibody named 34 Beta E12 that selectively identifies and binds to high molecular weight cytokeratins, a type of intermediate filament proteins present in the epithelial cells.</p>
<p>Cytokeratins are critical in maintaining the structural integrity of epithelial cells, playing a key role in cell differentiation and metabolic processes. Changes in the expression or structure of these proteins can often be associated with disease states, including various forms of cancer. Therefore, the IHC - 34 Beta E12 (HMWCK) test offers substantial insights into the diagnosis and management of numerous epithelial disorders, most notably malignancies such as carcinomas.
 </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">IHC - 34 Beta E12(HMWCK) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Tissue </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>None </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>3 Days
 </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹ 2000 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is the importance of getting the IHC - 34 Beta E12 (HMWCK) test done? </h2>
	<p>The <strong>IHC - 34 Beta E12 (HMWCK) test</strong> plays a crucial role in differentiating between carcinomas (cancers that begin in the skin or tissues lining internal organs) and other types of tumors or malignancies. It provides key insights into disease progression and can significantly influence decisions on therapeutic approaches.
 </p>
	<h2 class="test-h2 mt-3">Is fasting required for the IHC - 34 Beta E12 (HMWCK) test?
 </h2>
	<p>No, fasting is not required for the IHC - 34 Beta E12 (HMWCK) test. The test is performed on tissue samples obtained through biopsy or surgical procedures.
 </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">Is there any specific preparation required for this test?</h2>
<p>No specific preparation is needed for the IHC - 34 Beta E12 (HMWCK) test. Your healthcare provider will give you detailed instructions on how to prepare for the biopsy or surgical procedure, if necessary.</p>

	<h2 class="test-h2 mt-3">When should I get this test done?</h2>
<p>Your healthcare provider may recommend the IHC - 34 Beta E12 (HMWCK) test if there's a need to distinguish between a carcinoma and other types of malignancies. It can also be useful in determining the origin of metastatic carcinomas, contributing to the overall diagnosis and treatment plan.</p>

	<h2 class="test-h2 mt-3">What information does the IHC - 34 Beta E12 (HMWCK) test provide?</h2>
<p>The <strong>IHC - 34 Beta E12 (HMWCK) test</strong> identifies the presence and distribution of high molecular weight cytokeratins in tissue samples. This information aids in the diagnosis of various epithelial disorders, primarily carcinomas, and offers valuable insights into the disease's progression.</p>

	<h2 class="test-h2 mt-3">How often should this test be done?</h2>
<p>The frequency of the IHC - 34 Beta E12 (HMWCK) test will depend on your specific medical condition and the healthcare provider's judgment. It may be ordered when an initial diagnosis is being made, or at regular intervals to monitor the progression of the disease and the effectiveness of treatments.</p>

	<h2 class="test-h2 mt-3">What are the normal values for this test?</h2>
<p>This test is qualitative, indicating the presence or absence of high molecular weight cytokeratins in the tissue sample. As such, there are no typical "normal" or "abnormal" values. Results are interpreted by a pathologist in the context of your overall clinical picture.</p>

	<h2 class="test-h2 mt-3">What precautions should be taken before undergoing this test?</h2>
<p>There are no special precautions required for the IHC - 34 Beta E12 (HMWCK) test. However, if a biopsy or surgery is needed to acquire the tissue sample, your healthcare provider will provide specific guidelines regarding preparation and aftercare for these procedures.</p>

	<h2 class="test-h2 mt-3">What factors can affect the levels of HMWCK in the test?</h2>
<p>Factors such as the type, stage, and location of the tumor, as well as any current or previous treatments, can impact the expression of high molecular weight cytokeratins in the tissue sample.</p>

	<h2 class="test-h2 mt-3">Which doctor should I consult if my test results are abnormal?</h2>
<p>Abnormal results should be discussed with your primary healthcare provider or a specialist such as a pathologist or oncologist. They will interpret your results within the context of your overall health and medical history, providing a more accurate diagnosis and appropriate treatment plan.</p>

	<h2 class="test-h2 mt-3">Are there any risks associated with the IHC - 34 Beta E12 (HMWCK) test?</h2>
<p>The risks associated with the <strong>IHC - 34 Beta E12 (HMWCK) test</strong> are primarily tied to the biopsy or surgical procedure used to obtain the tissue sample. These can include infection, bleeding, or an adverse reaction to anesthesia. However, these risks are generally low, and your healthcare provider will take measures to mitigate them.</p>

	<h2 class="test-h2 mt-3">Does the IHC - 34 Beta E12 (HMWCK) test replace other diagnostic tests for carcinomas?</h2>
<p>While the IHC - 34 Beta E12 (HMWCK) test provides essential information, it is typically used in conjunction with other diagnostic tests, such as imaging studies or molecular tests, to create a comprehensive picture of the disease. It does not replace these other diagnostic tests but enhances the overall understanding of the disease.</p>

	<h2 class="test-h2 mt-3">How reliable is the IHC - 34 Beta E12 (HMWCK) test?</h2>
<p>The IHC - 34 Beta E12 (HMWCK) test is highly reliable when performed and interpreted by trained professionals. It has proven to be a vital tool in differentiating carcinomas from other types of tumors and evaluating disease progression.</p>

	<h2 class="test-h2 mt-3">Can medications affect the result of the IHC - 34 Beta E12 (HMWCK) test?</h2>
<p>The IHC - 34 Beta E12 (HMWCK) test analyzes the presence and distribution of cytokeratins in tissue samples, which typically are not directly affected by medications. However, certain treatments, such as chemotherapy or immunotherapy, might alter the cellular structure of the tumor, potentially influencing the test results.</p>

	<h2 class="test-h2 mt-3">Is the IHC - 34 Beta E12 (HMWCK) test applicable for all types of cancer?</h2>
<p>The <strong>IHC - 34 Beta E12 (HMWCK) test</strong> is primarily used for the evaluation of carcinomas, which originate from epithelial cells. While it may offer some insight into other types of cancer, its primary application lies in the diagnosis and management of epithelial malignancies.</p>

<p>Taking into account these insights, the IHC - 34 Beta E12 (HMWCK) test serves as a pivotal piece of the diagnostic puzzle when dealing with carcinomas. The critical information it provides aids in choosing the most effective course of action for the patient's treatment, making it indispensable in the management of these types of malignancies. Always consult with your healthcare provider for any queries or concerns related to the procedure or its results.</p>

</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>